SE388434B - Framstellning av l-(alfas 5s)-alfa-amino-3-klor-2-isoxazolin-5 ettiksyra (benemnd at-125)genom odling av s. svicens - Google Patents

Framstellning av l-(alfas 5s)-alfa-amino-3-klor-2-isoxazolin-5 ettiksyra (benemnd at-125)genom odling av s. svicens

Info

Publication number
SE388434B
SE388434B SE7303352A SE7303352A SE388434B SE 388434 B SE388434 B SE 388434B SE 7303352 A SE7303352 A SE 7303352A SE 7303352 A SE7303352 A SE 7303352A SE 388434 B SE388434 B SE 388434B
Authority
SE
Sweden
Prior art keywords
svicens
alphas
isoxazoline
alfa
cultivation
Prior art date
Application number
SE7303352A
Other languages
English (en)
Inventor
L J Hanka
D G Martin
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE388434B publication Critical patent/SE388434B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00Antibiotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7303352A 1972-03-13 1973-03-09 Framstellning av l-(alfas 5s)-alfa-amino-3-klor-2-isoxazolin-5 ettiksyra (benemnd at-125)genom odling av s. svicens SE388434B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23434772A 1972-03-13 1972-03-13
US00329001A US3856807A (en) 1972-03-13 1973-02-02 L-({60 s,5s)-{60 -amino-3-chloro-2-isoxazoline-5-acetic acid

Publications (1)

Publication Number Publication Date
SE388434B true SE388434B (sv) 1976-10-04

Family

ID=26927835

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7303352A SE388434B (sv) 1972-03-13 1973-03-09 Framstellning av l-(alfas 5s)-alfa-amino-3-klor-2-isoxazolin-5 ettiksyra (benemnd at-125)genom odling av s. svicens

Country Status (13)

Country Link
US (1) US3856807A (sv)
JP (1) JPS5629997B2 (sv)
AR (1) AR198077A1 (sv)
AU (1) AU467524B2 (sv)
CA (1) CA984321A (sv)
CH (1) CH581698A5 (sv)
DK (1) DK132095C (sv)
FR (1) FR2183680B1 (sv)
GB (1) GB1382772A (sv)
IL (1) IL41598A (sv)
NL (1) NL7303331A (sv)
PH (1) PH9723A (sv)
SE (1) SE388434B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944562A (en) * 1974-04-17 1976-03-16 The Upjohn Company αS, 4S, 5R α-Amino-3-chloro-4-hydroxy-2-isoxazoline-5-acetic acid
US4298744A (en) * 1978-05-15 1981-11-03 The Upjohn Company Method for preparing (αS,5S)-α-amino-3-chloro-2-isoxazoline-5-acetic acid (AT-125) and analogs thereof
US4256898A (en) * 1978-05-15 1981-03-17 The Upjohn Company α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
AU526380B2 (en) * 1978-05-15 1983-01-06 Upjohn Company, The 2-isoxazoline-5-acetic acid derivatives
US4275214A (en) * 1978-05-15 1981-06-23 The Upjohn Company Substituted alkoxy carbonyl-3-oxo-α-phthalimido-5-isoxozolidineacetic acids
USRE31578E (en) * 1978-05-15 1984-05-01 The Upjohn Company α(Substituted) amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4225720A (en) * 1978-05-15 1980-09-30 The Upjohn Company Purification of AT-125
US4232164A (en) * 1978-05-15 1980-11-04 The Upjohn Company Purification of AT-125
US4692538A (en) * 1982-04-14 1987-09-08 Bristol-Myers Company Trichloroethanimidic acid esters
WO2014186435A2 (en) 2013-05-14 2014-11-20 University Of Georgia Research Foundation, Inc. Compositions and methods for reducing neointima formation
CA3163889A1 (en) 2019-12-04 2021-06-10 Ashvattha Therapeutics, Inc. Triantennary n-acetylgalactosamine modified hydroxyl polyamidoamine dendrimers and methods of use thereof
US20210170040A1 (en) 2019-12-04 2021-06-10 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery

Also Published As

Publication number Publication date
PH9723A (en) 1976-02-27
AU467524B2 (en) 1975-12-04
FR2183680A1 (sv) 1973-12-21
GB1382772A (en) 1975-02-05
JPS5629997B2 (sv) 1981-07-11
DK132095C (da) 1976-03-15
CH581698A5 (sv) 1976-11-15
AU5247773A (en) 1974-08-22
CA984321A (en) 1976-02-24
JPS4899391A (sv) 1973-12-15
FR2183680B1 (sv) 1976-10-22
IL41598A (en) 1975-11-25
AR198077A1 (es) 1974-05-31
US3856807A (en) 1974-12-24
NL7303331A (sv) 1973-09-17
DK132095B (da) 1975-10-20
IL41598A0 (en) 1973-04-30

Similar Documents

Publication Publication Date Title
DK145022C (da) Fremgangsmaade til fremstilling af amorfe,udfaeldede kiselsyrepigmenter
DK125794B (da) Analogifremgangsmåde til fremstilling af 2,3-dichlorphenoxyeddikesyrederivater.
SE400091B (sv) Framstellning av mutanas, ett alfa-1,3-glukanas, genom odling av mutanasalstrande mikroorganismer tillhorande trikoderma eller penicillium
SE400296B (sv) Forfarande for framstellning av derivat av cyklisk adenosin-3',5'-monofosforsyra
SE388434B (sv) Framstellning av l-(alfas 5s)-alfa-amino-3-klor-2-isoxazolin-5 ettiksyra (benemnd at-125)genom odling av s. svicens
DK133870B (da) Analogifremgangsmåde til fremstilling af substituerede phenoxycarboxylsyrederivater.
NO140101C (no) Fremgangsmaate til fremstilling av substituerte aminobenzosyrederivater
BE759063A (fr) Transformation d'aldoses en cetoses par fermentation.
SE416811B (sv) Analogiforfarande for framstellning av nya, antibakteriellt aktiva derivat av amidinopenicillansyra
SE416645B (sv) Forfarande for framstellning av 6-deoxitetracykliner genom katalytisk hydrogenering av eventuellt 11a-halogenerade 6-demetyl-6-deoxi-6-metylentetracykliner
DK144732C (da) Fremgangsmaade til fremstilling af amorfe,udfaeldede kiselsyrepigmenter
SE416725B (sv) Forfarande for framstellning av p-nitrobensoesyra
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
DK132434B (da) Analogifremgangsmåde til fremstilling af derivater af 6-aminopenicillansyre.
DK134279B (da) Analogifremgangsmåde til fremstilling af cycloalkylphenoxycarboxylsyrederivater.
DK134485B (da) Analogifremgangsmåde til fremstilling af thiocarbaminsyrederivater.
DK139778B (da) Fremgangsmåde til fremstilling af 6-aminopenicillansyre.
SE383510B (sv) Forfarande for framstellning av levulinsyra genom upphettning av furfurylalkohol.
DK133667B (da) Fremgangsmåde til fremstilling af 5-cyklohexyl-6-halogenindan-1-karboxylsyrederivater.
DK134154B (da) Analogifremgangsmåde til fremstilling af 5-cyklohexyl-1-indankarboxylsyrederivater.
DK140431B (da) Analogifremgangsmåde til fremstilling af et N2-dansyl-L-arginin-derivat eller syreadditionssalte deraf.
DK138490B (da) Fremgangsmåde til fremstilling af prostadiensyrederivater.
SE384214B (sv) Forfarande for framstellning av tetrabromftalsyraanhydrid genom bromering av ftalsyraanhydrid
DK130309B (da) Analogifremgangsmåde til fremstilling af 3-(3β-tridigitoxosyl-14β-hydroxy-5β-androstan-17β-yl)-acrylsyreforbindelser.
SE7700792L (sv) Forfarande for framstellning av n,n'-diklor-isoftalsyraamid